Watchlist Manager

Watchlist

Price: 39.44 USD -3.59%

Market Cap: 751.3m USD

Have any thoughts about
USANA Health Sciences Inc?

Write Note

Income Statement

Operating Income

Revenue	862m USD
Cost of Revenue	-165m USD
Gross Profit	697m USD
Operating Expenses	-614.7m USD
Operating Income	82.3m USD
Other Expenses	-28m USD
Net Income	54.3m USD

Currency: USD

		Sep-2014	Jan-2015	Apr-2015	Jul-2015	Oct-2015	Jan-2016	Apr-2016	Jul-2016	Oct-2016	Dec-2016	Apr-2017	Jul-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Jan-2021	Apr-2021	Jul-2021	Oct-2021	Jan-2022	Apr-2022	Jul-2022	Oct-2022	Dec-2022	Apr-2023	Jul-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024
Revenue
Revenue		749 N/A	791 +6%	828 +5%	872 +5%	914 +5%	919 +1%	940 +2%	965 +3%	986 +2%	1 006 +2%	1 021 +1%	1 020 0%	1 027 +1%	1 047 +2%	1 084 +4%	1 128 +4%	1 163 +3%	1 189 +2%	1 170 -2%	1 125 -4%	1 089 -3%	1 061 -3%	1 055 -1%	1 058 +0%	1 095 +4%	1 135 +4%	1 176 +4%	1 254 +7%	1 230 -2%	1 187 -4%	1 151 -3%	1 079 -6%	1 038 -4%	999 -4%	974 -2%	948 -3%	928 -2%	921 -1%	900 -2%	875 -3%	862 -2%
Gross Profit
Cost of Revenue		(137)	(141)	(145)	(151)	(157)	(160)	(164)	(170)	(174)	(180)	(180)	(178)	(180)	(179)	(186)	(192)	(197)	(201)	(197)	(194)	(190)	(188)	(188)	(189)	(198)	(209)	(221)	(230)	(224)	(218)	(212)	(204)	(200)	(194)	(191)	(185)	(181)	(177)	(171)	(168)	(165)
Gross Profit		612 N/A	650 +6%	682 +5%	722 +6%	757 +5%	759 +0%	775 +2%	795 +2%	812 +2%	826 +2%	841 +2%	842 +0%	847 +1%	868 +2%	898 +3%	936 +4%	966 +3%	989 +2%	973 -2%	931 -4%	899 -3%	873 -3%	867 -1%	869 +0%	898 +3%	926 +3%	955 +3%	1 024 +7%	1 005 -2%	969 -4%	940 -3%	875 -7%	838 -4%	805 -4%	783 -3%	763 -3%	747 -2%	744 0%	729 -2%	707 -3%	697 -1%
Operating Income
Operating Expenses		(499)	(534)	(561)	(591)	(618)	(617)	(630)	(651)	(670)	(687)	(703)	(709)	(719)	(735)	(755)	(775)	(791)	(800)	(793)	(771)	(749)	(727)	(717)	(710)	(729)	(749)	(774)	(828)	(814)	(798)	(781)	(740)	(721)	(697)	(682)	(667)	(656)	(651)	(638)	(623)	(615)
Selling, General & Administrative		(499)	(528)	(561)	(591)	(618)	(611)	(630)	(651)	(670)	(682)	(703)	(709)	(719)	(726)	(755)	(775)	(791)	(791)	(793)	(771)	(749)	(717)	(717)	(710)	(729)	(738)	(774)	(828)	(814)	(787)	(781)	(740)	(721)	(686)	(682)	(667)	(656)	(640)	(638)	(622)	(615)
Research & Development		0	(5)	0	0	0	(6)	0	0	0	(5)	0	0	0	(9)	0	0	0	(9)	0	0	0	(10)	0	0	0	(11)	0	0	0	(11)	0	0	0	(12)	0	0	0	(11)	0	0	0
Operating Income		113 N/A	116 +3%	121 +4%	131 +8%	139 +7%	142 +2%	145 +3%	144 -1%	142 -2%	139 -2%	138 -1%	133 -4%	129 -3%	133 +3%	143 +8%	162 +13%	176 +9%	188 +7%	180 -4%	160 -11%	150 -6%	146 -3%	150 +3%	159 +6%	169 +6%	177 +5%	182 +3%	196 +8%	191 -2%	170 -11%	159 -7%	135 -15%	117 -14%	108 -8%	101 -6%	96 -5%	91 -5%	93 +2%	91 -2%	84 -7%	82 -2%
Pre-Tax Income
Interest Income Expense		1	0	0	0	1	1	1	1	1	1	1	2	2	2	3	3	4	4	5	5	5	5	4	3	1	2	2	2	4	3	3	2	3	4	5	6	8	9	10	11	11
Total Other Income		(1)	(1)	(1)	(1)	(1)	(0)	(1)	(1)	(1)	(1)	(0)	(1)	(0)	0	0	(1)	(1)	(1)	(1)	(1)	(1)	(0)	(1)	(1)	(1)	(1)	(0)	(1)	(1)	(2)	(2)	(2)	(2)	(3)	(2)	(1)	(1)	0	(0)	(1)	(1)
Pre-Tax Income		113 N/A	116 +3%	121 +4%	130 +8%	139 +7%	143 +2%	146 +2%	145 -1%	142 -2%	139 -3%	139 +0%	134 -4%	130 -3%	135 +4%	145 +8%	164 +13%	178 +9%	192 +7%	184 -4%	165 -10%	154 -6%	151 -2%	153 +2%	161 +5%	169 +5%	178 +5%	183 +3%	197 +8%	194 -2%	171 -12%	160 -6%	135 -16%	117 -13%	109 -7%	104 -4%	101 -2%	99 -3%	102 +4%	101 -1%	94 -7%	93 -2%
Net Income
Tax Provision		(37)	(39)	(41)	(44)	(47)	(48)	(48)	(47)	(40)	(39)	(40)	(38)	(40)	(42)	(45)	(53)	(60)	(65)	(62)	(56)	(52)	(50)	(50)	(51)	(53)	(53)	(54)	(59)	(58)	(54)	(51)	(45)	(41)	(39)	(39)	(38)	(39)	(39)	(39)	(39)	(38)
Income from Continuing Operations		76	77	80	86	92	95	97	98	102	100	99	97	90	93	100	111	118	126	121	109	102	101	103	110	116	125	129	139	136	117	108	89	77	69	65	63	60	64	62	55	54
Net Income (Common)		76 N/A	77 +1%	80 +4%	86 +8%	92 +7%	95 +3%	97 +3%	98 +0%	102 +5%	100 -2%	99 -1%	97 -3%	90 -7%	63 -31%	70 +12%	81 +15%	88 +9%	126 +44%	121 -4%	109 -10%	102 -6%	101 -2%	103 +2%	110 +6%	116 +6%	125 +8%	129 +3%	139 +8%	136 -2%	117 -14%	108 -7%	89 -18%	77 -14%	69 -10%	65 -6%	63 -3%	60 -6%	64 +7%	62 -3%	55 -11%	54 -1%
EPS (Diluted)		2.85 N/A	2.8 -2%	3.04 +9%	3.24 +7%	3.45 +6%	3.59 +4%	3.86 +8%	3.92 +2%	4.07 +4%	3.99 -2%	3.96 -1%	3.86 -3%	3.67 -5%	2.53 -31%	2.88 +14%	3.25 +13%	3.51 +8%	5.12 +46%	5.07 -1%	4.65 -8%	4.59 -1%	4.41 -4%	4.76 +8%	5.19 +9%	5.46 +5%	5.86 +7%	6.08 +4%	6.8 +12%	6.71 -1%	5.73 -15%	5.55 -3%	4.65 -16%	3.98 -14%	3.59 -10%	3.39 -6%	3.28 -3%	3.09 -6%	3.3 +7%	3.21 -3%	2.86 -11%	2.83 -1%

Income Statement Balance Sheet Cash Flow Statement

Income Statement Balance Sheet Cash Flow Statement

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Join more than 198,500+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.